During the past year, in an effort to increase shareholder value, the likes of Abbot and Pfizer have split or sold off divisions. In February, Sir Andrew Witty of GSK announced cost cuts of £1 billion by 2016. Such slash and burn tactics, however, can be avoided by using advanced procurement strategies whilst retaining valuable assets within the business.